Previous studies on the lymphocyte subset counts showed close relations between (i) CD4+ and CD8+ T cell counts and (ii) disease severity and clinical outcome, and suggested that the CD4+ and CD8+ T cell counts in patients with COVID-19 could be good biomarkers of COVID-19 activity [21,22]. Here, CD4 is linked to COVID-19.